Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic Statin Use and Reduced Risk of Repeat Retinal Detachment Repair: A Retrospective Cohort Study.

Maria Anna Bantounou1, Dimitra Foteinou2, Konstantinos G Baroutis1

  • 1Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

Ophthalmology. Retina
|June 29, 2026
PubMed
Summary

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant and adjuvant therapy in uveal melanoma: toward systemic control of a systemic disease.

Cancer treatment reviews·2026
Same author

Reference map of multimodal vision deficits in intermediate age-related macular degeneration: contrast sensitivity and low-contrast visual acuity.

The British journal of ophthalmology·2026
Same author

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

American journal of ophthalmology·2026
Same author

Cataract Surgery and the Risk of Conversion from Dry to Neovascular Age-related Macular Degeneration in the IRIS© Registry.

Ophthalmology·2026
Same author

Recent vaccination exposure and central serous chorioretinopathy.

Eye (London, England)·2026
Same author

Neuroprotective Agents for Photoreceptor Rescue Following Experimental Retinal Detachment in Rodents: A Systematic Review.

Investigative ophthalmology & visual science·2026
This summary is machine-generated.

Preoperative statin use was linked to a reduced risk of repeat retinal detachment (RD) repair within one year. Simvastatin showed the most significant association with lower recurrence rates, suggesting potential benefits in RD management.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Retinal Diseases

Background:

  • Recurrent retinal detachment (RD) after primary repair is a significant cause of vision loss.
  • Proliferative vitreoretinopathy, a key driver of recurrent RD, involves hypoxia-inducible factor (HIF)-regulated pathways.
  • Statins, known for anti-inflammatory and anti-fibrotic effects, are indirect HIF inhibitors.

Purpose of the Study:

  • To investigate the association between preoperative statin use and the risk of repeat RD repair within one year of primary repair.
  • To evaluate the efficacy of statins in mitigating vision loss associated with recurrent RD.

Main Methods:

  • A retrospective cohort study utilizing a propensity-matched design.
  • Patients aged ≥30 undergoing primary RD repair were identified and matched 1:1 based on various clinical factors.
Keywords:
Statinhypoxia-inducible factorproliferative vitreoretinopathyretinal detachment

Related Experiment Videos

  • Statin exposure was defined as >90 days of use within 12 months pre-surgery, with Cox proportional hazards models used for analysis.

    • Main Results:

    • Statin users (n=1,232) showed a lower rate of repeat RD repair (16.1%) compared to controls (21.1%) within one year (HR=0.75, P=0.0014).
    • Active-comparator analysis revealed a reduced risk for statin users versus proton pump inhibitor users (HR=0.71, P=0.0224).
    • Simvastatin specifically demonstrated a significant association with reduced repeat RD repair risk (HR=0.59, P=0.0356 adjusted).

    Conclusions:

    • Preoperative statin use is associated with a decreased risk of repeat RD repair.
    • Simvastatin emerged as the most promising statin subclass in this analysis.
    • Further prospective studies are warranted to confirm causality and optimize statin-based strategies for preventing RD recurrence.